Actelion Throws Restless Shareholders First Dividend
Reuters Hedgeworld › February 18, 2011
Linked as:
Summary
ALLSCHWIL, Switzerland (Reuters) - Swiss biotech group Actelion, facing pressure from its largest shareholder to put itself up for sale after a spate of product setbacks, proposed its first dividend to rally support for its goal to stay independent.
Actelion, long seen as a takeover target, also revealed it had missed full-year net profit estimates with a figure of 390.6 million Swiss francs ($404 million), although sales of its top seller, heart and lung drug Tracleer, were in line.See the full content of this document
Extract
Actelion Throws Restless Shareholders First Dividend
By 12:16 p.m. GMT, shares in the group were 1.3 percent stronger at 54.45 francs. Actelion stock has been rangebound bet...
See the full content of this document
Sponsored links
